# Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.

> **NCT05519813** · PHASE4 · UNKNOWN · sponsor: **Bing He** · enrollment: 60 (estimated)

## Conditions studied

- Polycystic Ovary Syndrome

## Interventions

- **DRUG:** Metformin
- **DRUG:** Pioglitazone Hydrochloride And Metformin Hydrochloride Tablets

## Key facts

- **NCT ID:** NCT05519813
- **Lead sponsor:** Bing He
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-01-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2023-03-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2022-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05519813

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05519813, "Effects of Pioglitazone Combined With Metformin on Gonadal and Metabolic Profiles in Chinese Nonobese PCOS Patients.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05519813. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*